Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR9.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR2.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR1.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR3.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR5.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR8.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR7.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR6.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR22.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR23.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR13.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR24.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR17.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR11.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR19.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR15.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR27.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR12.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR14.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR25.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR16.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR26.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR10.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR18.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR20.htm
EX-10.1 - EXHIBIT 10.1 - HEALTH DISCOVERY CORPex10-1.htm
EX-32.1 - EXHIBIT 32.1 - HEALTH DISCOVERY CORPex32-1.htm
EX-10.2 - EXHIBIT 10.2 - HEALTH DISCOVERY CORPex10-2.htm
EX-31.1 - EXHIBIT 31.1 - HEALTH DISCOVERY CORPex31-1.htm
10-Q - FORM 10-Q - HEALTH DISCOVERY CORPt74989_10q.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR21.htm
v2.4.0.6
Statements of Operations (unaudited) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Revenues:        
Licensing & Development $ 731,894 $ 32,155 $ 1,293,960 $ 89,172
Operating Expenses:        
Amortization 65,680 65,680 197,040 197,040
Professional and Consulting Fees 100,590 159,494 442,059 470,408
Legal Fees 110,210 9,137 174,901 115,116
Research & Development Fees 24,118 10,980 97,267 139,514
Compensation 270,079 267,676 929,227 855,537
Other General and Administrative Expenses 151,225 169,482 600,311 470,413
Total Operating Expenses 721,902 682,449 2,440,805 2,248,028
Income / (Loss) From Operations 9,992 (650,294) (1,146,845) (2,158,856)
Other Income (Expense)        
Realized Gain on Sale of Available for Sale Securities (Note G) 337,841   337,841  
Unrealized Gain on Investment in Available for Sale Securities (Note G) 1,135,380   1,502,580  
Interest Income 67 1,439 1,059 5,554
Gain on Payables Restructuring       483,658
Total Other Income (Expense) 1,473,288 1,439 1,841,480 489,212
Net Income / (Loss) 1,483,280 (648,855) 694,635 (1,669,644)
Preferred Stock Dividends 34,965 35,343 454,398 109,015
Earnings / (Loss) Attributable to Common Shareholders $ 1,448,315 $ (684,198) $ 240,237 $ (1,778,659)
Weighted Average Outstanding Shares - basic (in shares) 232,457,588 230,725,747 231,907,958 230,031,303
Earnings Per Share (basic) (in dollars per share) $ 0.006 $ (0.003) $ 0.001 $ (0.007)
Weighted Average Outstanding Shares - diluted (in shares) 249,826,717 230,725,747 232,523,320 230,031,303
Earnings Per Share (diluted) (in dollars per share) $ 0.006 $ (0.003) $ 0.001 $ (0.007)